Skip to main content
SpringerLink
Log in

Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Campo E, Raffeld M, Jaffe ES (1999) Mantle-cell lymphoma. Semin Hematol 36(2):115–127 (review)

    PubMed  CAS  Google Scholar 

  2. Goy A (2007) Mantle cell lymphoma: evolving novel options. Curr Oncol Rep 9(5):391–398 (review), doi:10.1007/s11912-007-0053-9

    Article  PubMed  CAS  Google Scholar 

  3. Manabe A, Murti KG, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Campana D (1994) Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood 83(3):758–766

    PubMed  CAS  Google Scholar 

  4. Merville P, Déchanet J, Desmoulière A, Durand I, de Bouteiller O, Garrone P, Banchereau J, Liu YJ (1996) −Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J Exp Med 183(1):227–236. doi:10.1084/jem.183.1.227

    Article  PubMed  CAS  Google Scholar 

  5. Corral LG, Haslett PA, Muller GW, Chen R, Wong LM, Ocampo CJ, Patterson RT, Stirling DI, Kaplan G (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol 163(1):380–386

    PubMed  CAS  Google Scholar 

  6. Settles B, Stevenson A, Wilson K, Mack C, Ezell T, Davis MF, Taylor LD (2001) Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide. Cell Mol Biol 47(7):1105–1114

    PubMed  CAS  Google Scholar 

  7. Kaufmann H, Raderer M, Wöhrer S, Püspök A, Bankier A, Zielinski C, Chott A, Drach J (2004) Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma. Blood 104(8):2269–2271. doi:10.1182/blood-2004-03-1091

    Article  PubMed  CAS  Google Scholar 

  8. Damaj G, Lefrère F, Delarue R, Varet B, Furman R, Hermine O (2003) Thalidomide therapy induces response in relapsed mantle cell lymphoma. Leukemia 17(9):1914–1915. doi:10.1038/sj.leu.2403058

    Article  PubMed  CAS  Google Scholar 

  9. Wilson EA, Jobanputra S, Jackson R, Parker AN, McQuaker IG (2002) Response to thalidomide in chemotherapy-resistant mantle cell lymphoma: a case report. Br J Haematol 119(1):128–130. doi:10.1046/j.1365-2141.2002.03810.x

    Article  PubMed  Google Scholar 

  10. Smith SM, Grinblatt D, Johnson JL, Niedzwiecki D, Rizzieri D, Bartlett NL, Cheson BD, Cancer and Leukemia Group B (2008) Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B. Br J Haematol 140(3):313–319. doi:10.1111/j.1365-2141.2007.06937.x

    Article  PubMed  CAS  Google Scholar 

  11. Wang M, Fayad L, Hegemeister F et al (2007) A phase I/II study of lenalidomide in combination with rituximab in relapsed/refractory mantle cell lymphoma with early evidence of efficacy. J Clin Oncol 25:8030

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Hematology, Institute of Cancerology and Hematology, CHU Morvan, Avenue Foch, 29609, Brest, France

    Adrian Tempescul, Jean-Christophe Ianotto & Christian Berthou

  2. Laboratory of Haematology, CHU Morvan, Avenue Foch, 29609, Brest, France

    Veronique Marion

  3. Laboratory of Histology, Embryology and Cytogenetics, Faculty of Medicine and Health Sciences, Université de Bretagne Occidentale, 22, avenue Camille Desmoulins, CS 93837, 29238, Brest cedex 3, France

    Frederic Morel & Marc De Braekeleer

Authors
  1. Adrian Tempescul
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Christophe Ianotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Frederic Morel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Veronique Marion
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marc De Braekeleer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christian Berthou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adrian Tempescul.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tempescul, A., Ianotto, JC., Morel, F. et al. Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma. Ann Hematol 88, 921–922 (2009). https://doi.org/10.1007/s00277-008-0692-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-008-0692-4

Keywords

Search

Navigation